189 related articles for article (PubMed ID: 8564721)
1. Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy.
McHugh SM; Deighton J; Stewart AG; Lachmann PJ; Ewan PW
Clin Exp Allergy; 1995 Sep; 25(9):828-38. PubMed ID: 8564721
[TBL] [Abstract][Full Text] [Related]
2. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.
Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J
Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602
[TBL] [Abstract][Full Text] [Related]
3. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures.
Jutel M; Pichler WJ; Skrbic D; Urwyler A; Dahinden C; Müller UR
J Immunol; 1995 Apr; 154(8):4187-94. PubMed ID: 7706753
[TBL] [Abstract][Full Text] [Related]
4. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.
Akdis CA; Akdis M; Blesken T; Wymann D; Alkan SS; Müller U; Blaser K
J Clin Invest; 1996 Oct; 98(7):1676-83. PubMed ID: 8833918
[TBL] [Abstract][Full Text] [Related]
5. Wasp venom immunotherapy induces a shift from IL-4-producing towards interferon-gamma-producing CD4+ and CD8+ T lymphocytes.
Schuerwegh AJ; De Clerck LS; Bridts CH; Stevens WJ
Clin Exp Allergy; 2001 May; 31(5):740-6. PubMed ID: 11422133
[TBL] [Abstract][Full Text] [Related]
6. Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-gamma production of T cells.
Pierkes M; Bellinghausen I; Hultsch T; Metz G; Knop J; Saloga J
J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):326-32. PubMed ID: 9949326
[TBL] [Abstract][Full Text] [Related]
7. Systemic T-cell unresponsiveness during rush bee-venom immunotherapy.
Segura JA; Assenmacher M; Irsch J; Hunzelmann N; Radbruch A
Allergy; 1998 Mar; 53(3):233-40. PubMed ID: 9542602
[TBL] [Abstract][Full Text] [Related]
8. Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils.
Jutel M; Müller UR; Fricker M; Rihs S; Pichler WJ; Dahinden C
Clin Exp Allergy; 1996 Oct; 26(10):1112-8. PubMed ID: 8911695
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells in children undergoing rush venom immunotherapy.
Ajduk J; Turkalj M; Gagro A
Allergy Asthma Proc; 2012; 33(6):525-30. PubMed ID: 23394512
[TBL] [Abstract][Full Text] [Related]
10. Selective restimulation of antigen or allergen preactivated T cells using OKT3 F(ab)2 results in the secretion of TH-1 or TH-2-like cytokine patterns.
Jutel M; Wyss-Coray T; Carballido JM; Blaser K; Müller UR; Pichler WJ
Clin Exp Allergy; 1995 Nov; 25(11):1108-17. PubMed ID: 8581844
[TBL] [Abstract][Full Text] [Related]
11. The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific T helper cells.
Carballido JM; Faith A; Carballido-Perrig N; Blaser K
Eur J Immunol; 1997 Feb; 27(2):515-21. PubMed ID: 9045925
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cell and cytokine changes in children undergoing 3 days rush venom immunotherapy.
Rattanamanee T; Lumjiaktase P; Kemawichanura N; Kiewgnam P; Jotikasthira W; Manuyakorn W
Asian Pac J Allergy Immunol; 2023 Sep; 41(3):193-198. PubMed ID: 33068370
[TBL] [Abstract][Full Text] [Related]
13. Importance of the inducible costimulator molecule for the induction of allergic immune responses and its decreased expression on T helper cells after venom immunotherapy.
Bellinghausen I; Klostermann B; Böttcher I; Knop J; Saloga J
Immunology; 2004 May; 112(1):80-6. PubMed ID: 15096187
[TBL] [Abstract][Full Text] [Related]
14. Venom immunotherapy modulates interleukin-4 and interferon-gamma messenger RNA expression of peripheral T lymphocytes.
Akoum H; Tsicopoulos A; Vorng H; Wallaert B; Dessaint JP; Joseph M; Hamid Q; Tonnel AB
Immunology; 1996 Apr; 87(4):593-8. PubMed ID: 8675214
[TBL] [Abstract][Full Text] [Related]
15. Ultra rush bee venom immunotherapy does not reduce cutaneous weal responses to bee venom and codeine phosphate.
Jutel M; Skrbic D; Pichler WJ; Müller UR
Clin Exp Allergy; 1995 Dec; 25(12):1205-10. PubMed ID: 8821301
[TBL] [Abstract][Full Text] [Related]
16. Impaired secretion of interleukin-4 and interleukin-13 by allergen-specific T cells correlates with defective nuclear expression of NF-AT2 and jun B: relevance to immunotherapy.
Faith A; Richards DF; Verhoef A; Lamb JR; Lee TH; Hawrylowicz CM
Clin Exp Allergy; 2003 Sep; 33(9):1209-15. PubMed ID: 12956740
[TBL] [Abstract][Full Text] [Related]
17. Expression of Th1, Th2, lymphocyte trafficking and activation markers on CD4+ T-cells of Hymenoptera allergic subjects and after venom immunotherapy.
Cabrera CM; Urra JM; Alfaya T; Roca Fde L; Feo-Brito F
Mol Immunol; 2014 Nov; 62(1):178-85. PubMed ID: 25004111
[TBL] [Abstract][Full Text] [Related]
18. Modulation of T-cell response to phospholipase A2 and phospholipase A2-derived peptides by conventional bee venom immunotherapy.
Kämmerer R; Chvatchko Y; Kettner A; Dufour N; Corradin G; Spertini F
J Allergy Clin Immunol; 1997 Jul; 100(1):96-103. PubMed ID: 9257793
[TBL] [Abstract][Full Text] [Related]
19. Kinetics and functional implications of Th1 and Th2 cytokine production following activation of peripheral blood mononuclear cells in primary culture.
McHugh S; Deighton J; Rifkin I; Ewan P
Eur J Immunol; 1996 Jun; 26(6):1260-5. PubMed ID: 8647202
[TBL] [Abstract][Full Text] [Related]
20. Gangliosides GD1b, GT1b, and GQ1b enhance IL-2 and IFN-gamma production and suppress IL-4 and IL-5 production in phytohemagglutinin-stimulated human T cells.
Kanda N; Watanabe S
J Immunol; 2001 Jan; 166(1):72-80. PubMed ID: 11123278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
